Menu

Studies Show How Cells Differentiate at Life’s Beginning

A trio of papers provide new insight into embryo development.

Apr 27, 2018
Shawna Williams

A zebrafish embryoSTILL FROM A VIDEO BY FENGZHU XIONG AND SEAN MEGASON/HMSBy profiling gene expression in thousands of embryonic zebrafish and frog cells, researchers at Harvard University have refined the picture of how early development occurs. In a trio of papers published yesterday (April 26) in Science, two separate research groups also compare results to find common and divergent features of the embryos of zebrafish and frogs.

“With single-cell sequencing, we can, in a day’s work, recapitulate decades of painstaking research on the decisions cells make at the earliest stages of life,” says Allon Klein, an author of two of the papers, in a statement.

In all of the studies, the researchers separated individual cells in embryos and analyzed which messenger RNA molecules were present in them to build a profile of which genes were in use. One of the studies then computationally pieced together different stages of development over the first day of growth for a zebrafish embryo. Another examined how embryonic cells differentiate in frogs, and how the process compared with that of zebrafish. In the third paper, also performed on zebrafish, researchers found that, surprisingly, cells that had started down a path to becoming one type of differentiated cell could switch and pursue a different fate.

“I think the future of development will be to routinely single-cell sequence embryos,” Detlev Arendt, an evolutionary developmental biologist at the European Molecular Biology Laboratory in Heidelberg, Germany, who was not involved in the studies, tells Science.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.